Commercialised

√ – Filed,  * Under filing

Product USDMF CEP EDMF China DMF CADIFA Brazil KDMF Russia Others Therapeutic Use
Apixaban √ * * √ √ * * TDMF, JDMF Anticoagulant
Aripiprazole √ √ * * * √ * JDMF Antipsychotic/Antidepressant
Articaine HcI √ * √ * Dental Anesthetic
Atomoxetine HcI √ √ * √ TDMF, Canada Attention Deficit Hyperactivity Disorder (ADHD)
Baclofen √ √ * * * √ * * JDMF Skeletal Muscle Relaxant
Betahistine DiHcl √ * √ √ AntiVertigo
Brivudine √ Depending upon customer interest filing can be done Antiviral
Dapagliflozin propanediol monohydrate √ √ √ √ Antidiabetic
Dexmethylphenidate HcI Tech Pack Attention Deficit Hyperactivity Disorder (ADHD)
Diflunisal √ * √ NSAID
Dipyridamole √ √ * √ * √ √ TGA AntiPlatelet
Doxazosin Mesylate √ * √ √ Antihypertensive
Drotaverine Hcl √ √ √ AntiSpasmodic
Empagliflozin (Crystalline) √ * √ * * * JDMF Antidiabetic
Entacapone √ √ * √ √ √ * TDMF, *JDMF AntiParkinson
Flurbiprofen √ * √ * JDMF NSAID
Fluvoxamine Maleate √ √ * * * * * TDMF Antidepressant
Hydralazine HcI √ √ * * * JDMF Antihypertensive
Irinotecan Hcl √ Anti-Cancer
Lamotrigine √ √ * √ √ √ * * JDMF Antiepileptic
Lenalidomide (Form-A,Form-I,Form-B) * * * * * * * * JDMF Anti-Cancer
Levocetirizine DiHcl √ √ TDMF AntiHistamine
Levomepromazine Maleate √ * Antipsychotic
Lurasidone HcI √ Antipsychotic
Maraviroc √ TDMF Antiretroviral
Mebeverine √ * * * √ TGA, TDMF AntiSpasmodic
Meclizine HcI √ AntiHistamine
Methotrexate Anti-Cancer
Methylphenidate HcI √ * √ Attention Deficit Hyperactivity Disorder (ADHD)
Mexiletine HcI √ Antiarrhythmia
Midazolam √ √ * √ √ TDMF Anesthetic
Midazolam HcI √ √ Anesthetic
Midazolam Maleate Anesthetic
Mirabegron √ √ Treatment of overactive bladder
Pirfenidone √ √ * √ * √ AntiInflammatory / AntiRheumatic
Posaconazole √ * * * * * * JDMF Antifungal
Propiomazine Maleate √ √ Antipsychotic
Quetiapine Fumarate √ √ * √ √ √ TGA Antipsychotic
Ractopamine HcI √ Canada β Adrenergic Agonist(V)
Rivaroxaban √ √ * √ √ √ * * JDMF Anticoagulant
Tamsulosin HcI √ √ * √ √ TDMF Benign Prostatic Hyperplasia
Tapentadol Phosphate √ Anesthetic
Ticagrelor √ √ * √ √ * JDMF Platelet aggregation inhibitor
Tolcapone √ √ AntiParkinson
Venlafaxine HcI √ √ * √ * * * * JDMF Antidepressant
Verapamil HcI √ √ * √ Antihypertensive
Zonisamide √ √ √ TDMF, JDMF Anticonvulsant
Zonisamide √ √ Anticonvulsant
Vildagliptin * Antidiabetic
Empagliflozin * Antidiabetic
Mexiletine * * Antiarrhythmics
Bempedoic Acid * Antilipemic agent
Cannabidiol * Analgesic, Anticonvulsant, Muscle relaxant, Anxiolytic, Antipsychotic

Pipeline

Product Therapeutic Use Status
Benserazide Anti-Parkinsons Process validation Completed
Lisdexamfetamine dimesylate Attention deficit Hyperactivity disorder (ADHD) treatment,
Antidepressant, Schizophrenia treatment		 Process validation Completed
Dabigatran Antithrombotic Under process validation
Cilostazol Antithrombotic, Vasodilator Process validation Completed
Desvenlafaxine Antidepressant, Anxiolytic Development Completed. Process validation to start
Miglustat Fabry's Disease treatment, Gaucher Disease treatment Development Completed. Process validation to start
Oxymetazoline Decongestant, Vasoconstrictor Under process validation
Remimazolam Local anesthetics, Sedative Under process validation
Loxoprofen Analgesic, Anti-inflammatory Under process validation
Levodropropizine Antitussive, Cough suppressant Under process validation
Trimetazidine Anti-anginal Under process validation
Irinotecan Hydrochloride Oncology Development Completed. Process validation to start
Lenalidomide Form-A Oncology Development Completed. Process validation to start
Lenalidomide Form-B Oncology Development Completed. Process validation to start
Methotrexate Oncology Feasibility stage